International trends in primary liver cancer incidence from 1973 to 2007

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Zhang, Yue ^a   Ren, Jian Song ^a   Shi, Ju Fang ^a   Li, Ni ^a   Wang, Yu Ting ^a   Qu, Chunfeng ^a   Zhang, Yawei ^a,b   Dai, Min ^a  

^a CANCER HOSPITAL   (China)

^b YALE CANCER CENTER   (United States)

Author keywords

HBV; HCV; Incidence; International trends; Liver neoplasms

Indexed keywords

AGE; ALCOHOL CONSUMPTION; ARTICLE; ASIA; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; DISEASE ASSOCIATION; EUROPE; FEMALE; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LIVER CANCER; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PACIFIC ISLANDS; RISK FACTOR; SEX RATIO; TREND STUDY; VIRUS TRANSMISSION; WESTERN HEMISPHERE; HEALTH; HEALTH SURVEY; HISTORY; INCIDENCE; INFORMATION PROCESSING; LIVER NEOPLASMS; SEX DIFFERENCE;

AGE FACTORS; DATASETS AS TOPIC; FEMALE; GLOBAL HEALTH; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; POPULATION SURVEILLANCE; SEX FACTORS;

EID: 84928736324     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1113-4     Document Type: Article

References (48)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr , accessed on 20/01/2014.
2. National Cancer Institute. Surveillance, Epidemiology, and End Results Program http://seer.cancer.gov/statfacts/html/livibd.html (accessed on 28/10/2014).
3. Zeng H, Zheng R, Guo Y, Zhang S, Zou X, Wang N, et al. Cancer survival in China, 2003-2005: A population-based study. Int J Cancer. 2015;136(8):1921-30.
4. Tang D, Nagano H, Nakamura M, Wada H, Marubashi S, Miyamoto A, et al. Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma. J Gastrointest Surg. 2006;10(7):987-98.
5. El-Serag HB. Hepatocellular Carcinoma. N Engl J Med. 2011;365:1118-27.
6. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264-73.
7. Shih WL, Chang HC, Liaw YF, Lin SM, Lee SD, Chen PJ, et al. Influences of tobacco and alcohol use on hepatocellular carcinoma survival. Int J Cancer. 2012;131(11):2612-21.
8. Ezzati M, Riboli E. Behavioral and dietary risk factors for noncommunicable diseases. N Engl J Med. 2013;369(10):954-64.
9. Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett. 2009;286(1):9-14.
10. Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis. 2010;42:S206-14.
11. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JFJ. International trends and patterns of primary liver cancer. Int J Cancer. 2001;94(2):290-6.
12. Center MM, Jemal A. International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2011;20(11):2362-8.
13. Segi M. Cancer mortality for selected sites in 24 countries (1950-57). Sendai: Tohuku University School of Public Health; 1960.
14. Waterhouse J, Muir CS, Shanmugaratnam K, Powell J. Cancer Incidence in Five Continents, Vol. IV.IARC Scientific Publications No. 42, Lyon, IARC. 1982.
15. Muir CS, Waterhouse J, Mack T, Powell J, Whelan SL. Cancer Incidence in Five Continents, Vol. V. IARC Scientific Publications No. 88, Lyon, IARC. 1987.
16. Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powell J. Cancer Incidence in Five Continents, Vol. VI. IARC Scientific Publications No. 120, Lyon, IARC. 1992.
17. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents, Vol. VII. IARC Scientific Publications No. 143, Lyon, IARC. 1997.
18. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents, Vol. VIII. IARC Scientific Publications No. 155, Lyon, IARC. 2002.
19. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer Incidence in Five Continents, Vol. IX. IARC Scientific Publications No. 160, Lyon, IARC. 2007.
20. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, et al. Cancer Incidence in Five Continents, Vol. X (electronic version). Lyon, IARC. http://ci5.iarc.fr last accessed on [28/10/2013]. 2013.
21. Lortet-Tieulent J, Renteria E, Sharp L, Weiderpass E, Comber H, Baas P, et al. Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988-2010. Eur J Cancer. 2013; http://dx.doi.org/10.1016/j.ejca.2013.10.014 .
22. Surveillance, Epidemilology, and End Results (SEER) Program (November 2012 submission). Public use database (1973-1982). Surveillance Research Program, National Cancer Institute SEER*Stat software (seer.cancer.gov/seerstat) version < Version 8.0.4>, Released April 15, 2013.
23. Ferlay J, Parkin DM, Curado MP, Bray F, Edwards B, Shin HR, et al. Cancer Incidence in Five Continents, Volumes I to IX: IARC CancerBase No. 9 [Internet]. International Agency for Research on Cancer: Lyon, France; 2010. Available from: http://ci5.iarc.fr .
24. Jin F, Devesa SS, Chow WH, Zheng W, Ji BT, Fraumeni JF, et al. Cancer incidence trends in urban Shanghai, 1972-1994: an update. Int J Cancer. 1999;83(4):435-40.
25. Chiang CJ, Yang YW, You SL, Lai MS, Chen CJ. Thirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan. JAMA. 2013;310(9):974-6.
26. Chia KS, Lee HP, Lee J. Incidence of primary liver cancer in Singapore, 1968-1982. Ann Acad Med Singapore. 1989;18(3):313-6.
27. Lu W, Zheng Y. Prevalence and prevention measure of cancer in Shanghai. China Cancer. 2009;18:90-1.
28. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27(47):6550-7.
29. Ang LW, Cutter J, James L, Goh KT. Seroepidemiology of hepatitis B virus infection among adults in Singapore: a 12-year review. Vaccine. 2013;32(1):103-10.
30. Gao S, Yang WS, Bray F, Va P, Zhang W, Gao J, et al. Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005. Eur J Epidemiol. 2012;27(1):39-46.
31. Sun Z, Chen T, Thorgeirsson SS, Zhan Q, Chen J, Park JH, et al. Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China. Carcinogenesis. 2013;34(8):1800-5.
32. Yoshizawa H. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology. 2002;62 Suppl 1:8-17.
33. Tsukuma H. Liver cancer and its prevention. Asian Pac J Cancer Prev. 2005;6:244-50.
34. Hideo T, Yasuharu I, Naoki H, Yuri I, Kazuho I, Masahide O, et al. Declining Incidence of Hepatocellular Carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med. 2008;148:820-6.
35. Chung H, Ueda T, Kudo M. Changing trends in hepatitis C infection over the past 50 years in Japan. Intervirology. 2010;53(1):39-43.
36. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893-907.
37. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 1990;12:671-5.
38. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557-76.
39. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology. 2004;127(5):S5-16.
40. Maso LD, Lise M, Zambon P, Crocetti E, Serraino D, Ricceri F, et al. Incidence of primary liver cancer in Italy between 1988 and 2002: an age-period-cohort analysis. Eur J Cancer. 2008;44(2):285-92.
41. Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, Albertini A, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol. 2002;155(4):323-31.
42. Carlo LV. Alcohol and liver cancer. Eur J Cancer Prev. 2007;16(6):495-7.
43. Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Brit J Cancer. 2007;97(7):1005-8.
44. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625-38.
45. Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK, Fraumeni JF, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control. 2001;12(1):13-21.
46. Møller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer. 1994;30A:344-50.
47. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference. Hepatology. 2003;37(5):1202-19.
48. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745-50.